JPS59125052A - Continuous measuring device for blood sugar value - Google Patents

Continuous measuring device for blood sugar value

Info

Publication number
JPS59125052A
JPS59125052A JP57231910A JP23191082A JPS59125052A JP S59125052 A JPS59125052 A JP S59125052A JP 57231910 A JP57231910 A JP 57231910A JP 23191082 A JP23191082 A JP 23191082A JP S59125052 A JPS59125052 A JP S59125052A
Authority
JP
Japan
Prior art keywords
blood
blood sugar
value
electrode
sugar value
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57231910A
Other languages
Japanese (ja)
Other versions
JPH0262817B2 (en
Inventor
Tatsuo Suzuki
鈴木 辰生
Toshiaki Noda
野田 俊彬
Tetsuya Okuyama
奥山 哲哉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nikkiso Co Ltd
Original Assignee
Nikkiso Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nikkiso Co Ltd filed Critical Nikkiso Co Ltd
Priority to JP57231910A priority Critical patent/JPS59125052A/en
Publication of JPS59125052A publication Critical patent/JPS59125052A/en
Publication of JPH0262817B2 publication Critical patent/JPH0262817B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • C12Q1/005Enzyme electrodes involving specific analytes or enzymes
    • C12Q1/006Enzyme electrodes involving specific analytes or enzymes for glucose

Abstract

PURPOSE:To enable continuous measurement of the fluctuating blood sugar value of a patient without retardation by constituting a measuring part of a membrane for immobilizing glucose oxidizing enzyme and a hydrogen peroxide electrode having >=3:1 area ratio of a silver cathode and a platinum anode in measuring the concn. of the glucose in a sample liquid contg. glucose divided by incorporating a gaseous substance of 1/3-2 times volume of sample liquid in the continuous liquid flow of said sample. CONSTITUTION:A tube 38 for supplying a gaseous substance, for example, air, provided with a pump 36 is connected to a mixing tube 28 to divide the flow of a dilute blood by the air. The divided samples of the dilute blood are transferred to a measuring part 46 for a blood sugar value. The part 46 is constituted of, for example, an enzyme electrode 56 and a flow cell 59, and is capable of detecting, with time, the output corresponding to the blood sugar value of the samples of the dilute blood divided by the gaseous substance and supplied via an nozzle 58. The output obtd. with the electrode 56 is fed, via an amplifier, to an arithmetic circuit for the blood sugar value, by which the blood sugar value is calculated. If the ratio of the area of the silver cathode/the area of the platinum cathode of the hydrogen peroxide electrode is >=3, the measured value in a high concn. region does not show a low value as compared to the true value and the linearity in the output is assured.

Description

【発明の詳細な説明】 本発明は、血糖値連続測定装置、より詳細には少幇の血
液を患者から連続採取し、変動する患者血糖値を遅滞な
く連続測定する血糖値連続測定装置に関するものである
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a blood glucose level continuous measuring device, and more particularly to a blood glucose level continuous measuring device that continuously collects a small amount of blood from a patient and continuously measures the fluctuating blood glucose level of the patient without delay. It is.

1r1[糖値は生体の糖代謝状態を示すバロメータであ
り、主要な生体情報である。血糖値が異常を示す原因と
なる疾患は、糖尿病を始めとして肝疾患、内分泌疾患、
代謝性疾患、中枢神経系疾患等数多くある。また、食事
摂取、連動、ストレス(情動、感染、妊娠、発熱、手術
)等生理的原因でも血糖値は変動する。正常人の場合血
糖値は♂0〜/20W/dtの比較的狭い@囲に保たれ
ており、異常なほどの高値、低値を示すことはない。血
糖値がこの様に動的平衡状態を維持しているのは、生体
に血糖値を増加させる機構と消費する機構があり、両者
のバランスの上になりたっているからである。
1r1 [Glucose value is a barometer that indicates the state of sugar metabolism in the living body and is the main biological information. Diseases that cause abnormal blood sugar levels include diabetes, liver disease, endocrine disease,
There are many metabolic diseases, central nervous system diseases, etc. Blood sugar levels also fluctuate due to physiological causes such as food intake, interactivity, stress (emotions, infection, pregnancy, fever, surgery), etc. In normal people, blood sugar levels are kept within a relatively narrow range of 0 to 20 W/dt, and do not show abnormally high or low values. The reason why the blood sugar level maintains such a dynamic equilibrium state is that the living body has a mechanism for increasing blood sugar level and a mechanism for consuming it, and there is a balance between the two.

しかし、何らかの原因によりこのバランスが崩れると血
糖値は異常値を示すようになり、加療が必要な状態にな
る。患者によっては短時間の間に血糖値が急激に変動す
ることがあり、治療上の診断情報として、血糖値の連続
モニターが必要となる。また、血糖値はインスリンを始
めとして、グルカゴン、成長ホルモン、甲状腺ホルモン
等のホルモン分泌、あるいはある種の薬剤の投与き深い
関係があり、これらの夙係の検査、研究等のためにも血
糖値の連続モニターの必要性があるとされている。本発
明は、これら医学上の要望に答えるべきものとして開発
された血糖値連続測定装置に関するものである。
However, if this balance is disrupted for some reason, the blood sugar level will show an abnormal value, and medical treatment will be required. Depending on the patient, blood sugar levels may fluctuate rapidly over a short period of time, and continuous monitoring of blood sugar levels is required as diagnostic information for treatment. In addition, blood sugar levels are closely related to the secretion of hormones such as insulin, glucagon, growth hormone, and thyroid hormone, as well as the administration of certain drugs, and blood sugar levels are also important for testing and research related to these. There is a need for continuous monitoring of The present invention relates to a continuous blood glucose level measuring device developed to meet these medical needs.

近年、センサー技術、計測器技術の目覚しい発達により
、II][糖鎖測定用のグルコースセンサーが開発され
、それらを応用した血糖値連続測定装置が実用化されて
いる。これら従来の血糖値連続測定装置は一般に凝血防
d二剤を注入しながら血液を連続採取する手段と、採取
した血液を希釈する手段と、希釈された血液を移送する
手段と、移送される血液と連続的に接触して血糖値を測
定する手段と、測定された血液を連続的にJll’出す
る手段とから構成される。血液と連ii、を的に接触し
て血糖値を測定する手段は、反応時間が7分間以内の非
常に短い酵素電極が広く採用されている。 。
In recent years, with the remarkable development of sensor technology and measuring instrument technology, glucose sensors for measuring sugar chains have been developed, and continuous blood glucose level measuring devices using these sensors have been put into practical use. These conventional blood glucose level continuous measuring devices generally include a means for continuously collecting blood while injecting two anticoagulant drugs, a means for diluting the collected blood, a means for transporting the diluted blood, and a means for transporting the blood to be transported. It consists of a means for continuously contacting the blood glucose level and measuring the blood glucose level, and a means for continuously discharging the measured blood. Enzyme electrodes, which have a very short reaction time of 7 minutes or less, are widely used as means for measuring blood glucose levels by contacting blood with blood. .

血糖値連続測定装置の使用の目的は、一般に異常血a!
I(11′fを示すと予想される患者の血糖値を長時間
にわたって測定、監視することにある。
The purpose of using a continuous blood glucose level measuring device is generally to detect abnormal blood a!
The purpose of this method is to measure and monitor the blood glucose level of a patient expected to exhibit I (11'f) over a long period of time.

しかし、従来の血糖値連続測定装Fはこれらの目的を十
分に満足しているとは言えない。つまり、下記のような
問題点が存在する。
However, it cannot be said that the conventional blood glucose level continuous measuring device F fully satisfies these objectives. In other words, the following problems exist.

/ グルコース酸化酵素を固定化した酵素膜を用いた酵
素電極は高濃度領域で出力が真の血糖値に比べ低値を示
す傾向があり、出力直線性が欠ける。
/ Enzyme electrodes using enzyme membranes with immobilized glucose oxidase tend to have a lower output than the true blood glucose level in high concentration regions, and lack output linearity.

2 血中に含まれる蛋白質、脂Jjq、44が酵素電極
の膜に付着するため酵素m極の出力特性が経時的に変化
する。
2. Proteins and fats contained in the blood adhere to the membrane of the enzyme electrode, so the output characteristics of the enzyme m-pole change over time.

そこで、本発明者等は従来の血糖11ム連続測定装置の
欠点を全て克服し、血糖値の連続測定が可能な装置を得
るべく鋭意研究を重ねた結果、グルコースを含む試料液
の連続液流中に該試料液の%から2倍の容量のガス体を
混入することにより該試料液流を分割化し、該分割化さ
れた試料液中のグルコース濃度をグルツース酸化酵素固
定化膜と銀陰極と白金陽極の面積比が3弓を以上の過酸
化水素電極とから構成したことを特徴とする酵素’*極
で測定すれば、従来の血糖値連続測定装置6の有する問
題点が全て解決されうることを突き止めた。
Therefore, the present inventors have conducted intensive research to overcome all the drawbacks of the conventional blood glucose 11-mu continuous measuring device and to obtain a device that can continuously measure blood glucose levels. The sample liquid flow is divided by mixing a gas with a volume twice that of the sample liquid, and the glucose concentration in the divided sample liquid is determined between the glucose oxidase immobilized membrane and the silver cathode. All the problems of the conventional continuous blood glucose level measuring device 6 can be solved by measuring with an enzyme'* electrode characterized by comprising a platinum anode with an area ratio of 3 or more and a hydrogen peroxide electrode. I figured it out.

また、上述した特徴を有する装置を試作し、極めてすぐ
れた特性の血糖値連続測定装置を確認することができた
We also prototyped a device with the above-mentioned characteristics, and were able to confirm a continuous blood glucose level measuring device with extremely excellent characteristics.

本発明の一般的目的は、高濃度領域で、低値を示すこと
なく、出力直線性を有シ、長時間運転しても血中に含ま
れる儒白質、力旨質等による膜の汚れによる出力特性の
経時変化の見られない拙糖値連続測定装置を提供するこ
とにある。
The general purpose of the present invention is to maintain output linearity in a high concentration region without showing a low value, and to maintain output linearity even after long hours of operation due to membrane contamination caused by white matter, white matter, etc. contained in the blood. It is an object of the present invention to provide a continuous measuring device for sugar level in which the output characteristics do not change over time.

本発明に係る装置において使用するガス体は、試料流を
分割化および膜の汚れを防止することを主1」的として
混入するものであって、空気が好適であるが、酸素、二
酸化炭素、窒素、不活性ガス等あるいはこれらの混合体
でも差し支えない。
The gas used in the apparatus according to the present invention is mixed mainly to divide the sample flow and prevent fouling of the membrane, and air is preferable, but oxygen, carbon dioxide, Nitrogen, inert gas, etc., or a mixture thereof may also be used.

ガス体を試料流に混入する手段は、グルコ−スを含む試
料供給チューブとガス体供給チューブを・連通ずること
により、ガス体をポンプ等にて試料流に強制的に混入し
試料流を分、t、’Ij化するのが好ましい。ガス体は
試料流の%からり倍の容量を混入することにより7υれ
防止に効果のあることが実験から明らかとなった。
The means for mixing the gas into the sample flow is to connect the sample supply tube containing glucose with the gas supply tube, and forcefully mix the gas into the sample flow using a pump or the like to separate the sample flow. , t, 'Ij. It has been found from experiments that mixing the gas in a volume that is twice as large as the sample flow is effective in preventing 7υ deviations.

一本発明において使用する酵素電極はグルコース酸化酵
素(以下GODと略す)固定膜および銀陰極と白金陽極
とからなる過酸化水素電極から構成される。
One enzyme electrode used in the present invention is composed of a glucose oxidase (hereinafter abbreviated as GOD) immobilized membrane and a hydrogen peroxide electrode consisting of a silver cathode and a platinum anode.

次に試料液中のグルコースはGODにて次の醇化反応を
受ける。
Next, the glucose in the sample solution undergoes the next solubilization reaction at GOD.

グルツース十〇、 +H,O−一→グルコンC狭十H2
0゜上記反応にて発生した過酸化水素を過酸化水素電極
にて検知する。
Glutooth 10, +H, O-1 → Glucon C narrow 10H2
0°Hydrogen peroxide generated in the above reaction is detected with a hydrogen peroxide electrode.

過酸化水素電極では下記反応式にて発生した過酸化水素
を測定する。
The hydrogen peroxide electrode measures hydrogen peroxide generated according to the reaction formula below.

白金(電極: 市軸−→2H++O)+スθ−銀陰極:
  Ot +’lH”+’le−□ uH>0本発明者
等は鋭意研究を重ねた結果、血糖の高濃度領域で出力が
低値を示し、出力の直線性が欠如する原因が、大量に発
生した過酸化水素を白金陽極で酸化する際にその旭に見
合った酸素の還元反応が銀陰極で生じないためであるこ
とを見い出し、白金陽極での反応に見合った酸素の還元
反応が生じるための銀陰極の面積を検討した結果、銀面
積が白金陽極の面積の3倍以上好ましくは2倍以上必要
であることを明らかにした。
Platinum (electrode: City axis - → 2H++O) + Su θ - Silver cathode:
Ot +'lH"+'le-□ uH>0 As a result of intensive research, the inventors have found that the cause of the low output in the high blood sugar concentration region and the lack of linearity in the output is due to a large amount of We discovered that this is because when generated hydrogen peroxide is oxidized with a platinum anode, a reduction reaction of oxygen commensurate with the reaction at the silver cathode does not occur at the silver cathode. As a result of examining the area of the silver cathode, it was revealed that the area of silver needs to be at least three times, preferably at least twice, the area of the platinum anode.

次に、本発明に係る血糖幼逆続測定装置の実施例につき
添付図面を参照しながら以下詳細に説明する。
Next, embodiments of the blood glucose continuous measurement device according to the present invention will be described in detail below with reference to the accompanying drawings.

第1図は本発明装置の系統図を示すもので、参照省号I
Oは血液を採取する手段を構成するダブルルーメンカテ
ーテルである。このカテーテル10は、血液の凝固防止
剤としてヘパリン溶液をその貯槽/、2からポンプ/4
1.を介して供給しながら、生体よりポンプ/lの作用
下に血液を採取する。血液採取チューブ!乙に吸引され
たff+を液は、混合管2gに供給されて希釈液により
希釈される。希釈液はその貯槽30よりポンプj’ 2
を介して導出される希釈液供給チューブ3≠によって混
合管2gへ供給される。またこの混合管、2gにはポン
プ3Aを備えたガス体この場合には空気供給チューブ3
gが接続され希釈血液の流れを空気で分割化させ、血液
と希釈液との混合を良好にする一方、酵素電極の汚れを
防止する役割を果たす。ガス体で分割化された希釈血液
サンプルは、血糖値測定部t1.乙へ移送される。
Figure 1 shows a system diagram of the device of the present invention, with reference to Ministry No. I
O is a double lumen catheter constituting the means for collecting blood. This catheter 10 pumps a heparin solution as an anticoagulant for blood from a reservoir/2 to a pump/4.
1. Blood is collected from the living body under the action of a pump/l while being supplied through the pump. Blood collection tube! The ff+ liquid sucked into B is supplied to the mixing tube 2g and diluted with a diluent. The diluted liquid is pumped from the storage tank 30 by pump j'2
The diluent is supplied to the mixing tube 2g by the diluent supply tube 3≠ led out through the diluent supply tube 3≠. Also, this mixing tube 2g is a gas body equipped with a pump 3A, in this case an air supply tube 3
g is connected to divide the flow of diluted blood with air, which improves the mixing of the blood and diluent, and also serves to prevent the enzyme electrode from becoming contaminated. The diluted blood sample divided by the gaseous body is sent to the blood sugar level measuring section t1. Transferred to Party B.

血糖値測定部≠tは、例えば第2図に示すように、酵素
電極j6と70−七ル!りから構成され、このように構
成配置された酵素膜Vjts6に対し、ガス体で分割化
された希釈血液サンプルをサンプル供給ノズルstrを
介して供給することにより、酵素電極j&では連続供給
されるサンプルの血糖値に対応する出力を経時的に検出
することができる。j7はGODを固定化した酵素膜、
toはサンプルの排出ノズルを表す。
For example, as shown in FIG. 2, the blood glucose level measuring section≠t is the enzyme electrode j6 and 70-7! By supplying a diluted blood sample divided by a gaseous body to the enzyme membrane Vjts6 configured and arranged in this way through the sample supply nozzle str, the enzyme electrode j& can continuously supply the sample. The output corresponding to the blood sugar level can be detected over time. j7 is an enzyme membrane with GOD immobilized;
to represents the sample discharge nozzle.

酵素電極に用いる過酸化水素?1′L極70は、例えば
第3図に示すように、白金陽極72と銀陰極71とから
構成される。本実施例では白金面積3. /−に対して
銀面積が332−なる?1丁、極を用いた。73はリー
ド線、7グはコネクターを表1゜ 酵素電極stで得られた出力は、増巾器を介して血糖値
演算回路に送られ血糖値が算出される。
Hydrogen peroxide used in enzyme electrodes? The 1'L pole 70 is composed of a platinum anode 72 and a silver cathode 71, for example, as shown in FIG. In this example, the platinum area is 3. Is the silver area 332- for /-? One pole was used. 73 is a lead wire, and 7 is a connector. Table 1. The output obtained from the enzyme electrode st is sent to a blood sugar level calculation circuit via an amplifier, and the blood sugar level is calculated.

なお、ガス体を混入することにより血糖出力4/jがあ
る振巾を持つ場合、必要であれば出力値を半環(化して
もよい。
In addition, when the blood sugar output 4/j has a certain amplitude due to the mixing of a gaseous body, the output value may be converted into a semicircular form if necessary.

〈実施例/〉 家兎から採取した脱血液をサンプルに用いて、本発明に
係る試料連続流中へのガス体の混入効果を調べた。家兎
から採取した脱血液には、血糖値の変動を防止するため
解糖防止剤(弗化す) IJウム)を予め添加した。試
料液の連続流中にガス体を混入した場合としない場合の
比較データを第グ図に示す。実線はガス体を混入した場
合の血糖の連続測定データを表し、破線はガス体を混入
しない場合のデータを示す。ガス体を混入しない場合、
サンプルの血糖値が変らないのにもかかわらず出力値は
経時的に低下する傾向を示し、測定開始から/ど0分′
後には、開始時の値に対し約/θ〜/j%低い価となっ
た。
<Example/> The effect of mixing a gaseous body into the continuous flow of a sample according to the present invention was investigated using drained blood collected from a domestic rabbit as a sample. A glycolytic inhibitor (fluorinated IJum) was added in advance to the drained blood collected from domestic rabbits to prevent fluctuations in blood sugar levels. Figure 3 shows comparative data when a gas is mixed into the continuous flow of the sample liquid and when it is not. The solid line represents continuous blood sugar measurement data when a gaseous body is mixed, and the broken line represents data when a gaseous body is not mixed. If no gas is mixed,
Even though the blood sugar level of the sample did not change, the output value showed a tendency to decrease over time, and from the start of measurement /0 minutes
Later, the value was about /θ~/j% lower than the starting value.

一方、ガス体を混入すると、出カイII′Iは経時的に
もほぼ一定値を示し、ガス体の混入により、安定した出
力値が得られることが明らかである。なお、本実験例で
は試料液の約%の容量のガス体を混入した。
On the other hand, when a gas body is mixed in, the output power II'I shows a substantially constant value over time, and it is clear that a stable output value can be obtained by mixing a gas body. In this experimental example, a gas having a volume of approximately % of the sample liquid was mixed.

〈実施例コ〉 過酸化水素電極の白金陽極と銀陰極の面積化を変えた場
合の出力特性を調べた。銀+1+i 411v白金面積
の値が約/、1.3.10.、.20゜30.410.
jrOになる電極を作製し、高濃度のグルツース標準液
をサンプルとした場合の出力値を求めた結果を第5図に
示す。黒丸はグルコース濃度/、 000岬/di の
標準液をサンプルとした測定例、白丸はグルコース濃度
SOOη/dノ の標準液をサンプルとした測定例であ
る。銀/白金4(Qが約/、−の電極の場合、第5図デ
ータが示す如く、真値に比べ低値を示すが3以上の値を
持つ電極の場合には、標準液の濃度通りの出力値を示し
た。
<Example 1> The output characteristics were investigated when the areas of the platinum anode and silver cathode of the hydrogen peroxide electrode were changed. Silver + 1 + i 411v Platinum area value is approximately /, 1.3.10. ,.. 20°30.410.
FIG. 5 shows the results of determining the output value when an electrode with jrO was prepared and a high-concentration gluten standard solution was used as a sample. The black circles are measurement examples using a standard solution with a glucose concentration of /, 000 cape/di as a sample, and the white circles are measurement examples using a standard solution with a glucose concentration of SOOη/d. Silver/Platinum 4 (In the case of an electrode with Q of about /, -, the value will be lower than the true value as shown in the data in Figure 5, but in the case of an electrode with a value of 3 or more, the concentration will be the same as that of the standard solution. The output value was shown.

本実験の結果、過酸化水素TM、極の銀陰極面積/白金
陽極面積の値が3以上であれば、高濃度領域での測定値
が真値に比べ低値を示すことなく、出力ik m性の確
保されることが明らかになった。さらに銀陰極面積/白
金陽極面積の値がg以上では極めて安定していることが
明らかである。
As a result of this experiment, if the value of hydrogen peroxide TM, silver cathode area/platinum anode area of the electrode is 3 or more, the measured value in the high concentration region will not show a lower value than the true value, and the output ik m It became clear that sex is secured. Furthermore, it is clear that the value of silver cathode area/platinum anode area is extremely stable when it is greater than g.

以上、本発明の好適な実施例および効果を実証する実験
例につき説明したが、本発明はこれに限定されることな
く本発明の思想を逸脱せずにさらに多くの改良変更をな
しうろことは言う迄もない。
The preferred embodiments and experimental examples for demonstrating the effects of the present invention have been described above, but the present invention is not limited thereto, and many improvements and changes may be made without departing from the spirit of the present invention. Needless to say.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は本発明に係る血糖値連続測定装置の一実施例を
示す系統図、第1図は本発明装置に使用する血糖測定部
の断面図、第3図は本発明装置に使用する過酸化水素電
極の構成図、第弘図はガス体混入の効果を示す特注図、
第j′図は銀陰極と白金陽極の面積比とグルツース標準
液出力特性の関係を表すグラフである。 10・・・ダブルルーメンカテーテル /、2・・・貯 槽     /l・・・ポンプ/l・
 ・・ポンプ      !o1ム訃・シリコン細管)
t・・・血液採取系   、21・・・混合管3θ・・
・貯 m      3.2・・・ポンプ3グ・・・希
釈液供給管  36・・・ポンプ3r・・・ガス体供給
管  4I!o・・・混合フィルグ2・・・血糖値測定
部  、f乙・・ 酵素電極j7・ ・ ・fl膜  
    jg・ ・ ・サンプル供給ノズルjり・ ・
 ・フローセル    to・ ・ ・サンプル餌、出
ノズル名!・・・廃液+V      Xと・・・箱 
体70・・・過酸化水素電極 7/・・・銀陰極72・
・・白金陽極    73・・・リード線7弘・・・コ
ネクタ TIME (min ) 第5図 Ag/Pt  Rati。
FIG. 1 is a system diagram showing an embodiment of the blood glucose level continuous measuring device according to the present invention, FIG. 1 is a sectional view of a blood glucose measuring section used in the device of the present invention, and FIG. The configuration diagram of the hydrogen oxide electrode, Figure 1 is a custom-made diagram showing the effect of gas mixture,
Figure j' is a graph showing the relationship between the area ratio of the silver cathode and the platinum anode and the Glutooth standard solution output characteristics. 10...Double lumen catheter/, 2...Storage tank/l...Pump/l.
...Pump! o1m death/silicon tubule)
t...Blood collection system, 21...Mixing tube 3θ...
・Storage m 3.2... Pump 3g... Diluent supply pipe 36... Pump 3r... Gas supply pipe 4I! o...Mixed filter 2...Blood sugar level measuring section, f...Enzyme electrode j7...fl membrane
Sample supply nozzle...
・Flow cell to... ・Sample bait, output nozzle name! ...Waste liquid + V X and ... box
Body 70...Hydrogen peroxide electrode 7/...Silver cathode 72.
...Platinum anode 73...Lead wire 7Hiro...Connector TIME (min) Fig. 5 Ag/Pt Rati.

Claims (1)

【特許請求の範囲】[Claims] グルコースを含む試料液の連続液流中に該試料液の尿か
ら2倍の容量のガス体を混入することにより該試料液流
を分割化し、該分割化された試料液中のグルコース濃度
をグルコース酸化酵素電極で測定することを特徴とする
血糖値連続鴇1j定装置。
The continuous flow of sample liquid containing glucose is divided into two parts by mixing twice the volume of gas from urine in the sample liquid, and the glucose concentration in the divided sample liquid is adjusted to A continuous blood glucose level determination device characterized by measuring with an oxidase electrode.
JP57231910A 1982-12-29 1982-12-29 Continuous measuring device for blood sugar value Granted JPS59125052A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP57231910A JPS59125052A (en) 1982-12-29 1982-12-29 Continuous measuring device for blood sugar value

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57231910A JPS59125052A (en) 1982-12-29 1982-12-29 Continuous measuring device for blood sugar value

Publications (2)

Publication Number Publication Date
JPS59125052A true JPS59125052A (en) 1984-07-19
JPH0262817B2 JPH0262817B2 (en) 1990-12-26

Family

ID=16930966

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57231910A Granted JPS59125052A (en) 1982-12-29 1982-12-29 Continuous measuring device for blood sugar value

Country Status (1)

Country Link
JP (1) JPS59125052A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0295857U (en) * 1988-12-10 1990-07-31
EP1394534A3 (en) * 2002-08-23 2004-12-29 F.Hoffmann-La Roche Ag Apparatus for checking positioning and freedom from bubbles of a medical microsample in a flow measuring cell
JP2007527008A (en) * 2004-03-05 2007-09-20 ディラブ・イ・ルンド・アクチボラグ System and method for automatic collection of fluid samples

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0295857U (en) * 1988-12-10 1990-07-31
EP1394534A3 (en) * 2002-08-23 2004-12-29 F.Hoffmann-La Roche Ag Apparatus for checking positioning and freedom from bubbles of a medical microsample in a flow measuring cell
US7297241B2 (en) 2002-08-23 2007-11-20 Roche Diagnostics Operations, Inc. Method and a device for monitoring a medical microsample in the flow measuring cell of an analyzer
JP2007527008A (en) * 2004-03-05 2007-09-20 ディラブ・イ・ルンド・アクチボラグ System and method for automatic collection of fluid samples

Also Published As

Publication number Publication date
JPH0262817B2 (en) 1990-12-26

Similar Documents

Publication Publication Date Title
Sheridan et al. Intraoperative tissue oximetry in the human gastrointestinal tract
Yamaguchi et al. Noninvasively measuring blood glucose using saliva
US5330634A (en) Calibration solutions useful for analyses of biological fluids and methods employing same
EP0393054B1 (en) A process and system and measuring cell assembly for glucose determination
Schoonen et al. Development of a potentially wearable glucose sensor for patients with diabetes mellitus: design and in-vitro evaluation
US20050000806A1 (en) Biosensor for monitoring an analyte content with a partial voltage generated therefrom
US5615671A (en) Processes and devices for continuously monitoring levels of analyte
JP2606825B2 (en) Electrochemical battery sensor for continuous and short-term use in tissues and blood
US5640954A (en) Method and apparatus for continuously monitoring the concentration of a metabolyte
JP5085653B2 (en) Condensed glue course analyzer
Free et al. Respiratory gas tensions in tissues and fluids of the male rat reproductive tract
US20050000807A1 (en) Biosensor with multi-channel A/D conversion and a method thereof
US20010041830A1 (en) Apparatus for measurment and control of the content of glucose, lactate or other metabolites in biological fluids
Perdomo et al. Miniaturized real-time monitoring system for L-lactate and glucose using microfabricated multi-enzyme sensors
Wilkes et al. Respiratory, ventilatory, acid-base and ionoregulatory physiology of the white sucker Catostomus commersoni: the influence of hyperoxia
JP2010167130A (en) Body fluid collection apparatus and body fluid analyzer
JP2008506942A (en) Electrochemical sensor for measuring the partial pressure of carbon dioxide in living tissues in vivo or in vitro
Lagercrantz et al. Plasma catecholamines following nursing procedures in a neonatal ward
US7857759B2 (en) Extraction device, analyzer, extraction method, and analysis method
JPS59125052A (en) Continuous measuring device for blood sugar value
JPH0968533A (en) Biochemical substrate measuring device displaying chemical dose
Ward et al. An amperometric glucose sensor integrated into an insulin delivery cannula: in vitro and in vivo evaluation
Tremper et al. Pulse oximetry and oxygen transport
Eberhard Continuous oxygen monitoring of newborns by skin sensors
Mitsumori et al. A new approach to noninvasive measurement of blood glucose using saliva analyzing system